Skip to main content

Table 5 Association between cholesterol and HAART initiation, adjusted for the potential confounding factors of study participants at Burayu Health Center, Addis Ababa, Ethiopia, 2012

From: Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study

Variables

Lipid profile levels

TC ≥200 mg/dl

HDL < 40 mg/dl

LDL ≥130 mg/dl

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

Non-HAART*

1.00

1.00

1.00

HAART Initiated

5.46(2.81-10.61)

2.62(1.55-4.44)

3.89(1.76-8.61)

P-value

<0.0001

<0.0001

0.001

BMI ≤21.2*

1.00

1.00

1.00

BMI >21.2

1.90(1.03-3.50)

  

P-value

0.039

  
  1. HAART, highly active antiretroviral therapy; AOR, adjusted odds ratio; CI, confidence interval; BMI, body mass index; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; p, significance level; *Reference category.